MTOR and meningioma: The upregulation of α-synuclein is thought to contribute to aggressive phenotypes of meningiomas via the Akt/mTOR pathway, thus highlighting a possible role for Hsp110 in the development of malignant meningiomas by regulating the conformational stability of α-synuclein [76].